kanamycin sulfates- kanamycin sulfate powder
kdg impresa llc, aqion - kanamycin sulfates (unii: ow1n4g4r9w) (kanamycin - unii:ruc37xup2p) -
x- kanamycin sulfate powder
ax pharmaceutical corp - kanamycin sulfates (unii: ow1n4g4r9w) (kanamycin - unii:ruc37xup2p) - kanamycin 4.95 kg in 5 kg
kanamycin sulfate powder
ax pharmaceutical corp - kanamycin a sulfate (unii: j80ex28smq) (kanamycin a sulfate - unii:j80ex28smq) -
kanamycin sulfate powder
ax pharmaceutical corp - kanamycin a sulfate (unii: j80ex28smq) (kanamycin a - unii:eqk9q303c5) -
kanamycin injection solution
fresenius kabi usa, llc - kanamycin a sulfate (unii: j80ex28smq) (kanamycin a - unii:eqk9q303c5) - kanamycin a 333 mg in 1 ml
kanamycin sulfate injection 1000mg "meiji" (硫酸カナマイシン注射液1000mg「明治」)
meiji seika pharma co., ltd. - kanamycin sulfate - injection
kanamycin sulfate injection "meiji" (カナマイシン硫酸塩注射液1g「明治」)
meiji seika pharma co., ltd. - kanamycin sulfate - color, diameter mm, thick mm
neostigmine methylsulfate- neostigmine methylsulfate injection, solution
general injectables and vaccines, inc - neostigmine methylsulfate (unii: 98imh7m386) (neostigmine - unii:3982twq96g) - neostigmine methylsulfate 1 mg in 1 ml - neostigmine methylsulfate injection, a cholinesterase inhibitor, is indicated for reversal of the effects of nondepolarizing neuromuscular blocking agents (nmba) after surgery. neostigmine is contraindicated in patients with: - known hypersensitivity to neostigmine methylsulfate (known hypersensitivity reactions have included urticaria, angioedema, erythema multiforme, generalized rash, facial swelling, peripheral edema, pyrexia, flushing, hypotension, bronchospasm, bradycardia and anaphylaxis). - peritonitis or mechanical obstruction of the urinary or intestinal tracts. pregnancy risk summary there are no adequate or well-controlled studies of neostigmine methylsulfate injection in pregnant women. it is not known whether neostigmine methylsulfate injection can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. the incidence of malformations in human pregnancies has not been established for neostigmine as the data are limited. all pregnancies, regardless of drug e
kanamycin sulfate powder
kdg impresa llc, aqion - nitrofurazone (unii: x8xi70b5z6) (nitrofurazone - unii:x8xi70b5z6) -
kanamycin sulfate injection 1 g3 ml
pharmazen medicals pte ltd - kanamycin sulphate eqv kanamycin - injection - 1 g/3 ml - kanamycin sulphate eqv kanamycin 1 g/3 ml